Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis—A real-world evidence study

This real-world study showed beneficial impact of alemtuzumab on fatigue, cognition, depression, QoL, and treatment satisfaction. Improvement in patient disability, and caregiver-reported outcomes indicated enhanced patients' QoL.

Authors

Institutions

Publication Details

Journal
Multiple Sclerosis and Related Disorders
Published
2024-12-03
DOI
https://doi.org/10.1016/j.msard.2024.106214
Citations
1
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.42

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis—A real-world evidence study

Alessandra Protti, Eleonora Baldi, Øivind Torkildsen, Luca Massacesi et al.
1 citations
Multiple Sclerosis and Related Disorders
Multiple Sclerosis Research Studies
0.42
article

Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis—A real-world evidence study

Alessandra Protti, Eleonora Baldi, Øivind Torkildsen, Luca Massacesi, Matthias Kant, Massimiliano Mirabella, Umberto Aguglia, Valeria Barcella, Job van Exel, Damiano Paolicelli, Elisabeth Farbu, Giuseppe Salemi, Helle Hvilsted Nielsen, Jette Lautrup Frederiksen, Heidi Øyen Flemmen, Giacomo Lus, Cristoforo Comi, Milena Alessandra De Riz, Augusto Rini, Falzone Francesca Maria Antonella
article en
1 citations

Abstract

This real-world study showed beneficial impact of alemtuzumab on fatigue, cognition, depression, QoL, and treatment satisfaction. Improvement in patient disability, and caregiver-reported outcomes indicated enhanced patients' QoL.

Multiple Sclerosis and Related DisordersVol. 93
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” (IT), University of Southern Denmark (DK), Stavanger University Hospital (NO), Haukeland University Hospital (NO), Odense University Hospital (DK), Glostrup Hospital (DK), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Magna Graecia University (IT), Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT), Ospedale A. Perrino (IT), Ospedale Papa Giovanni XXIII (IT), Azienda Ospedaliero-Universitaria Careggi (IT), Telemark Hospital (NO), Istituto delle Scienze Neurologiche di Bologna (IT), University of Campania "Luigi Vanvitelli" (IT), Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo (IT), Sygehus Sønderjylland (DK), Ospedale Sant'Anna (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University of Bergen (NO), University of Florence (IT), University of Bari Aldo Moro (IT), Erasmus University Rotterdam (NL)
Sanofi
Openalex Percentile: Top 32%
Multiple Sclerosis Research Studies
0.42
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.